Editas Medicine, Inc. vs Pfizer, Inc. — Stock Comparison

EDIT
Editas Medicine, Inc.
$2.90
▼ 3.33%
vs
PFE
Pfizer, Inc.
$26.33
▼ 1.39%
Q·Score Winner
Pfizer, Inc.
PFE6.5/10vs 4.9/10

Q·Score Breakdown

4.9
Bearish
Overall
6.5
Neutral
1.6
Quality
7.4
7.7
Health
7
4.3
Growth
5.6
6.8
Valuation
6.7
5.2
Sentiment
5.2
EDIT

Healthy balance sheet and financial position.

low return on equity (-198%).

PFE

Strong profitability with 12% net profit margins.

analyst sentiment is cautious.

Analyst Consensus

HOLD
Target $5.72 (+97.3%)
9 analysts
HOLD
Target $29.00 (+10.2%)
27 analysts

Fundamentals

EDIT
PFE
Trailing P/E
19.4×
-3.3×
Forward P/E
9.4×
0.0%
Profit Margin
12.4%
-122.0%
Gross Margin
75.8%
-198.1%
ROE
8.9%
-19.2%
Revenue Growth
-1.2%
Earnings Growth
2.04
Beta
0.39
Price / Book
$284M
Market Cap
$149.8B
$1 – $5
52-Week Range
$22 – $29

Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →